US 9675633
miRNA for treating cancer and for use with adoptive immunotherapies
granted A61KA61K31/7105A61K45/06
Quick answer
US patent 9675633 (miRNA for treating cancer and for use with adoptive immunotherapies) held by The Board of Regents of the University of Texas System expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K31/7105, A61K45/06, A61K9/127, A61P